[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 26, Number 101 (4-2017) ::
3 2017, 26(101): 83-87 Back to browse issues page
Octreotide use in the Treatment of Recurrent Hypoglycemia in a Suicidal Patient with Insulin and Glibenclamide
H Mohammadi Kojidi *, M Rahbar Taramsari, A Badsar, A Razavi, MS Attarchi
Guilan University of Medical Sciences
Abstract:   (683 Views)

Introduction: Hypoglycemia attack a clinical case of sulfonylureas toxicity in patients considered. Given the vulnerability of the brain in the long hypoglycemia in plasma glucose concentrations have returned to normal as quickly as possible, as well as the recurrence must be prevented.

Case Report: Fifty -year-old female patient without past history of diabetes with decreased level of consciousness by emergency medicine serves (EMS) administration of naloxone was taken to the hospital. The patient on admission GCS of 12, the patient's blood sugar and potassium, respectively, 40 and 2.8 mg per dl, the patient was alert with infusion of 50% glucose. The patients in the first and second days despite treatment with hypertonic dextrose infusion and oral diet with relapse of hypoglycemia as loss of consciousness, sweating and was restless. Because of recurrent hypoglycemia, the third day, Octreotide was administered at a dose of 50 mg subcutaneously every 12 hours. Number of relapses of hypoglycemia was reduced. The fourth day, Octreotide were changed to 50 mg every 6 hours and hypoglycemia attacks stopped.

Discussion and Conclusion: Typically in the treatment of hypoglycemia caused by poisoning oral anti-diabetes drugs such as Glibenclamide and insulin the Hypertonic glucose injection and is used for patients starting oral feeding. But it seems that Octreotide listed on the timing of the dose to treat patients with acute poisoning with sulfonylurea, hypoglycemia with frequent recurrences are to be effective.

Conflict of interest: none declared.

Keywords: Hypoglycemia, Octreotide, Recurrence
Full-Text [PDF 157 kb]   (215 Downloads)    
Type of Study: Research | Subject: Special
Received: 2017/05/1 | Accepted: 2017/05/1 | Published: 2017/05/1
Add your comments about this article
Your username or email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi Kojidi H, Rahbar Taramsari M, Badsar A, Razavi A, Attarchi M. Octreotide use in the Treatment of Recurrent Hypoglycemia in a Suicidal Patient with Insulin and Glibenclamide. 3. 2017; 26 (101) :83-87
URL: http://journal.gums.ac.ir/article-1-1406-en.html
Volume 26, Number 101 (4-2017) Back to browse issues page
مجله دانشگاه علوم پزشکی گیلان Journal of Guilan University of Medical Sciences

The journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Persian site map - English site map - Created in 0.139 seconds with 820 queries by yektaweb 3430